Principal Investigator
Nathan Carberry
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20250620
Clinical Trial Summary
COYA C302-CLN-2301: Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-Center, 24-Week Study with Additional 24-Week Open Label Extension (OLE) to Evaluate the Safety and Efficacy of COYA 302 for the Treatment of Amyotrophic Lateral Sclerosis (ALS).
Phase
TBD
Funding Agency/Sponsor
Industry
Disease
Other
Contact Information
Study Contact
Julie Steele
Phone Number
+1 (305) 7759502
Email
j.steele@miami.edu